Tessera
Folgen

Mike Schultz

@michael-schultz.bsky.social

Life sciences VC @Portal Innovations 🔬 Previously @Health Advances 💊 PhD at Harvard with David Sinclair lab on aging🧬 Opinions my own 🤷‍♂️

58 Posts1285 Follower3209 Folgt
Mike Schultz@michael-schultz.bsky.social · 7mo ago

Very cool paper showing a NAMPT activator that restores NAD+ in the brain can prevent Alzheimer's onset in an amyloid-driven 5xFAD mouse model. More evidence of a metabolic basis for neurodegenerative diseases. www.cell.com/cell-reports...

Pharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brain

Chaubey et al. demonstrate that restoration of brain resilience reverses advanced disease in two different mouse models of Alzheimer’s disease (AD), challenging the century-long dogma of AD irreversib...

cell.com

Stand Up for Science!@standupforscience.net · last yr.

Tax Day - round 3 - NIH 🩻🧠🧬 🧬 The average U.S. taxpayer contributes $105/year to NIH, helping fund: • Cancer & rare disease breakthroughs • Pandemic preparedness • Children’s health • Medical tech innovation • Mental health science & more NIH powers the science behind the healthcare we rely on.

A serious medical scene shows a healthcare worker in surgical scrubs standing in a hospital corridor. Bold white text overlays the image, reading: “Curing cancer. Preventing pandemics. What’s it worth?”A dark blue graphic with white text centered over a soft-focus medical background. The message reads: “Just $105 per year from the average taxpayer funds the national institute of health. That’s all it takes to help save lives improve care, and fight disease”A clean, square infographic with a dark blue background and light blue accents. The header reads, “What does that money actually do? Your $105 helps fund:” followed by six icons and descriptions: 1. Mental Health Research – Depression, PTSD, addiction 2. Cancer & Rare Disease Studies – From early detection to lifesaving treatments 3. Pandemic Preparedness – Vaccines, virus tracking, prediction and prevention 4. Children’s Health – Brain development, neonatal and pediatric care 5. Medical Innovation – Imaging, prosthetics, diagnostics 6. Basic Biomedical Science – Foundational research for future cures
Mike Schultz@michael-schultz.bsky.social · last yr.

Sustained support for the NIH, NSF, FDA, and other science agenices is what has made American the best place in the world for biomedical innovation. It's important that we preserve it. Watch Portal's John Flavin on CNBC!

Portal Innovation's Founder on the impact of NIH funding cuts on long-term drug development

John Flavin, Portal Innovations Founder & CEO, joins 'Fast Money' to talk how NIH funding cuts could be detrimental for the U.S. pharmaceutical industry and drug development.

cnbc.com

Laura White@laurakwhite.bsky.social · last yr.

There’s no argument that should reassure anyone enough to go back to business as usual, because none of these actions are happening in isolation. The war on US science won’t end with a court order on indirects.

Jonathan Howard@joho.bsky.social · 2y ago

This is the former dean of Harvard med school. He defended several pandemic misinformation doctors from “uncivil” tone, while dunking on those of us who tried to sound the alarm about misinformation agents. I tried to warn him and he got furious with me.

BildBild
Prasad Jallepalli, MD, PhD@prasad.bsky.social · 2y ago

unusual for NIH directors — most have experience in basic, translational, and/or clinical research not to mention records of leading large biomedical research enterprises, pioneering their field of study, and a combination of visibility and service to the research community

Jeremy Berg@jeremymberg.bsky.social · 2y ago

I checked Jay Bhattacharya's funding history 4 grants (all from NIA) Center on the Demography and Economics of Health and Aging Health Insurance Provision for Vulnerable Populations Exploring Medicare Provider Networks: Implications for Adoption of CER Findings External Costs of Obesity

Mike Schultz@michael-schultz.bsky.social · 2y ago

Nice interview from @biotechtv.bsky.social Brad Loncar with CEO Sarah Hein of March Bio, which raised a $28M series A. Portal invested in the seed round. March Bio is making T cells that kill other T cells. www.biotechtv.com/post/march-b...

Texas Life Science Forum: March Biosciences closed a $28.4M series A round last month to advance its CD5 targeting CAR-T

CEO Sarah Hein describes the rationale for CD5, and share her experience of what it was like making the raise come together.Sara FullBrought to you by

biotechtv.com

Mike Schultz@michael-schultz.bsky.social · 2y ago

Earlier this week had had our 2nd ever Portal Innovations book club on Breaking Through, the autobiography of Katalin Karikó who won a Nobel Prize for her work on modified mRNA that enabled the COVID vaccines.

BildBildBildBild